181 related articles for article (PubMed ID: 30753655)
21. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
[TBL] [Abstract][Full Text] [Related]
22. Antidepressant-resistant depression is characterized by reduced short- and long-interval cortical inhibition.
Jeng JS; Li CT; Lin HC; Tsai SJ; Bai YM; Su TP; Chang YW; Cheng CM
Psychol Med; 2020 Jun; 50(8):1285-1291. PubMed ID: 31155020
[TBL] [Abstract][Full Text] [Related]
23. Whole blood transcriptional signatures associated with rapid antidepressant response to ketamine in patients with treatment resistant depression.
Cathomas F; Bevilacqua L; Ramakrishnan A; Kronman H; Costi S; Schneider M; Chan KL; Li L; Nestler EJ; Shen L; Charney DS; Russo SJ; Murrough JW
Transl Psychiatry; 2022 Jan; 12(1):12. PubMed ID: 35013133
[TBL] [Abstract][Full Text] [Related]
24. An episode level evaluation of the treatment journey of patients with major depressive disorder and treatment-resistant depression.
Wu B; Cai Q; Sheehan JJ; Benson C; Connolly N; Alphs L
PLoS One; 2019; 14(8):e0220763. PubMed ID: 31393922
[TBL] [Abstract][Full Text] [Related]
25. Health-related quality of life burden associated with treatment-resistant depression in UK patients: Quantitative results from a mixed-methods non-interventional study.
Rathod S; Denee T; Eva J; Kerr C; Jacobsen N; Desai M; Baldock L; Young AH
J Affect Disord; 2022 Mar; 300():551-562. PubMed ID: 34965398
[TBL] [Abstract][Full Text] [Related]
26. Overview of treatment-resistant depression.
Li CT
Prog Brain Res; 2023; 278():1-23. PubMed ID: 37414489
[TBL] [Abstract][Full Text] [Related]
27. A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression.
Zhang C; Li Z; Wu Z; Chen J; Wang Z; Peng D; Hong W; Yuan C; Wang Z; Yu S; Xu Y; Xu L; Xiao Z; Fang Y
Psychopharmacology (Berl); 2014 Feb; 231(4):685-93. PubMed ID: 24114429
[TBL] [Abstract][Full Text] [Related]
28. Abnormal expression profile of plasma-derived exosomal microRNAs in patients with treatment-resistant depression.
Li LD; Naveed M; Du ZW; Ding H; Gu K; Wei LL; Zhou YP; Meng F; Wang C; Han F; Zhou QG; Zhang J
Hum Genomics; 2021 Aug; 15(1):55. PubMed ID: 34419170
[TBL] [Abstract][Full Text] [Related]
29. Low-dose ketamine for treatment resistant depression in an academic clinical practice setting.
Feifel D; Malcolm B; Boggie D; Lee K
J Affect Disord; 2017 Oct; 221():283-288. PubMed ID: 28666206
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of treatment resistant depression among major depressive disorder patients in Israel.
Sharman Moser S; Chodick G; Gelerstein S; Barit Ben David N; Shalev V; Stein-Reisner O
BMC Psychiatry; 2022 Aug; 22(1):541. PubMed ID: 35948895
[TBL] [Abstract][Full Text] [Related]
31. The medial forebrain bundle as a deep brain stimulation target for treatment resistant depression: A review of published data.
Gálvez JF; Keser Z; Mwangi B; Ghouse AA; Fenoy AJ; Schulz PE; Sanches M; Quevedo J; Selvaraj S; Gajwani P; Zunta-Soares G; Hasan KM; Soares JC
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():59-70. PubMed ID: 25530019
[TBL] [Abstract][Full Text] [Related]
32. Significantly decreased mRNA levels of BDNF and MEK1 genes in treatment-resistant depression.
Hong W; Fan J; Yuan C; Zhang C; Hu Y; Peng D; Wang Y; Huang J; Li Z; Yu S; Liu X; Wu Z; Chen J; Yi Z; Xu L; Fang Y
Neuroreport; 2014 Jul; 25(10):753-5. PubMed ID: 24709918
[TBL] [Abstract][Full Text] [Related]
33. Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study.
Wu Z; Chen J; Yuan C; Hong W; Peng D; Zhang C; Cao L; Fang Y
J Affect Disord; 2013 Sep; 150(3):834-9. PubMed ID: 23570952
[TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamic and pharmacokinetic evaluation of buprenorphine + samidorphan for the treatment of major depressive disorder.
Ragguett RM; Rong C; Rosenblat JD; Ho RC; McIntyre RS
Expert Opin Drug Metab Toxicol; 2018 Apr; 14(4):475-482. PubMed ID: 29621905
[TBL] [Abstract][Full Text] [Related]
35. Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder.
Murrough JW; Collins KA; Fields J; DeWilde KE; Phillips ML; Mathew SJ; Wong E; Tang CY; Charney DS; Iosifescu DV
Transl Psychiatry; 2015 Feb; 5(2):e509. PubMed ID: 25689570
[TBL] [Abstract][Full Text] [Related]
36. Intranasal esketamine: A novel drug for treatment-resistant depression.
Khorassani F; Talreja O
Am J Health Syst Pharm; 2020 Aug; 77(17):1382-1388. PubMed ID: 32729898
[TBL] [Abstract][Full Text] [Related]
37. Defining treatment-resistant depression.
Gaynes BN; Lux L; Gartlehner G; Asher G; Forman-Hoffman V; Green J; Boland E; Weber RP; Randolph C; Bann C; Coker-Schwimmer E; Viswanathan M; Lohr KN
Depress Anxiety; 2020 Feb; 37(2):134-145. PubMed ID: 31638723
[TBL] [Abstract][Full Text] [Related]
38. Ketamine Minus the Trip: New Hope for Treatment-Resistant Depression.
Abbasi J
JAMA; 2017 Nov; 318(20):1964-1966. PubMed ID: 29117311
[No Abstract] [Full Text] [Related]
39. Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression.
Martinotti G; Dell'Osso B; Di Lorenzo G; Maina G; Bertolino A; Clerici M; Barlati S; Rosso G; Di Nicola M; Marcatili M; d'Andrea G; Cavallotto C; Chiappini S; De Filippis S; Nicolò G; De Fazio P; Andriola I; Zanardi R; Nucifora D; Di Mauro S; Bassetti R; Pettorruso M; McIntyre RS; Sensi SL; di Giannantonio M; Vita A;
Bipolar Disord; 2023 May; 25(3):233-244. PubMed ID: 36636839
[TBL] [Abstract][Full Text] [Related]
40. Treatment resistant depression: A multi-scale, systems biology approach.
Akil H; Gordon J; Hen R; Javitch J; Mayberg H; McEwen B; Meaney MJ; Nestler EJ
Neurosci Biobehav Rev; 2018 Jan; 84():272-288. PubMed ID: 28859997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
